eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
2/2007
vol. 32
 
Share:
Send email
Share:
abstract:

Clinical immunology
Vascular endothelial growth factor (VEGF) in circulating blood of patients treated with enoxaparine after orthopaedic surgery

Leszek Jung
,
Barbara J. Bałan
,
Ewa Skopińska-Różewska
,
Joanna Chorostowska-Wynimko
,
Andrzej K. Siwicki
,
Ewa Sommer
,
Adriana Roży
,
Piotr Skopiński

(Centr Eur J Immunol 2007; 32 (2): 61-65)
Online publish date: 2007/07/31
View full text Get citation
 
VEGF, a potent mitogen for endothelial cells, is one of the most important cytokines responsible for stimulating angiogenesis. Some data confirm an important role of VEGF in wound and bone healing. In the blood, VEGF is present in plasma and, as important intracellular pool, in neutrophils and platelets. Intracellular VEGF is released to the serum upon these cells activation during coagulation.
Low-molecular weight heparins (LMWHs) are routinely used as anti-coagulants for prophylaxis after bone surgery. In the previous study, performed in seven patients after orthopedic surgery, we have found that enoxaparine injections administered during post-operative two weeks, have increased angiogenic activity and VEGF level in their sera. To elucidate the origin of this cytokine, in the present study we compared VEGF level in matched plasma and serum samples collected from 12 persons before, and 14 days after surgery and daily enoxaparine (40 mg) injections. The results were also compared to the findings obtained for sera collected from 30 healthy blood donors.
Both serum and plasma samples collected after enoxaparine treatment presented higher in vivo angiogenic activity in mouse cutaneous test than before administration of this drug.
No differences in plasma VEGF were observed. However, VEGF concentration in matched sera samples was significantly higher after surgery and enoxaparine treatment than before the beginning of the study.
Conclusion: intracellular VEGF, released during coagulation process plays an important role in in vivo angiogenic activity of serum, and its concentration significantly increased after 2-weeks enoxaparine treatment.
keywords:

VEGF, angiogenesis, orthopedic patients, enoxaparine
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.